To test effect of the ECM and CML-ECM on myofibroblast transformation, we quantified the levels of αSma protein in lung resident fibroblasts treated with media, the ECM, or the CML-ECM. The gene discussed is ACTA1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.